Esozet-LS Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, formulated to provide effective treatment for gastrointestinal disorders. Levosulpiride is a prokinetic agent that enhances gastrointestinal motility by blocking dopamine receptors, thereby improving symptoms such as nausea, vomiting, bloating, and abdominal discomfort commonly associated with functional dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying. Esomeprazole, a proton pump inhibitor (PPI), reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in the stomach lining, promoting healing of erosive esophagitis and preventing acid-related damage to the esophagus and stomach. The sustained-release (SR) formulation ensures a gradual and prolonged release of the active ingredients, enhancing therapeutic efficacy and improving patient compliance by reducing dosing frequency. Esozet-LS Capsule SR is indicated for the management of GERD, functional dyspepsia, gastric ulcers, and other acid-related gastrointestinal conditions where both acid suppression and improved motility are required. It should be used under medical supervision, especially in patients with liver or kidney impairment, and is contraindicated in individuals with hypersensitivity to its components. Common side effects may include headache, dizziness, and mild gastrointestinal disturbances.